SCHEMBL116032

SCHEMBL116032

COc1ccc(CO[C@@H]2C[C@@H](CO)N(C(=O)OCc3ccccc3)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 2/20 0.47
ALDH1A1 P00352 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
SIGMAR1 Q99720 1/20 0.45
TP53 P04637 1/20 0.45
ABCB1 P08183 1/20 0.45
P2RX4 Q99571 1/20 0.44
ITGB3 P05106 3/20 0.43
ITGB1 P05556 3/20 0.43
ITGAV P06756 3/20 0.43
ITGA5 P08648 3/20 0.43
ITGB5 P18084 3/20 0.43
MMP1 P03956 1/20 0.43
MMP3 P08254 1/20 0.43
MMP7 P09237 1/20 0.43
MMP9 P14780 1/20 0.43
MMP13 P45452 1/20 0.43
ITGA2B P08514 2/20 0.43
PARP1 P09874 1/20 0.42
CHRM5 P08912 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL116901 0.92 BDKRB2 (0.46) BDKRB2ALDH1A1NPSR1TP53ABCB1
SCHEMBL114544 0.89 BDKRB2 (0.45) BDKRB2ALDH1A1NPSR1TP53ABCB1
SCHEMBL3400542 0.89 ABCB1 (0.45) BDKRB2ALDH1A1NPSR1TP53ABCB1
SCHEMBL115938 0.89 ABCB1 (0.45) BDKRB2ALDH1A1NPSR1TP53ABCB1
SCHEMBL178628 0.88 ABCB1 (0.44) BDKRB2ALDH1A1NPSR1TP53ABCB1
SCHEMBL116041 0.86 AGTR2 (0.48) BDKRB2ALDH1A1NPSR1TP53P2RX4
SCHEMBL30054860 0.85 ABCB1 (0.44) BDKRB2ABCB1ITGB3ITGB1ITGAV
SCHEMBL18569430 0.85 ABCB1 (0.44) BDKRB2ABCB1ITGB3ITGB1ITGAV
SCHEMBL16402973 0.85 ABCB1 (0.44) BDKRB2ABCB1ITGB3ITGB1ITGAV
SCHEMBL6319947 0.85 POLB (0.45) ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120058989-A1 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS ACHAOGEN, INC. (US) 2012-03-08 US disclosed
US-20120058989-A1 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS ACHAOGEN, INC. (US) 2012-03-08 US disclosed
US-20120058989-A1 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS ACHAOGEN, INC. (US) 2012-03-08 US disclosed
EP-2250171-A2 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS Achaogen, Inc. (US) 2010-11-17 EP disclosed
WO-2009137130-A2 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS ACHAOGEN, INC. (US) 2009-11-12 WO disclosed
WO-2009137130-A2 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS ACHAOGEN, INC. (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058989-A1 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS RECQL, BLVRB, NQO2 BDKRB2 677/4885ALDH1A1 1678/4885NPSR1 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.